Home › Triple-Negative Breast Cancer › Wisconsin › Milwaukee
Triple-Negative Breast Cancer clinical trials in Milwaukee, WI
3 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Milwaukee (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
RecruitingPhase 3
- Ascension St. Francis Reiman Cancer Center, Franklin · 12 mi away
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
RecruitingPhase 1
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
RecruitingPhase 1/2
- Froedtert & the Medical College of Wisconsin, Milwaukee
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in Milwaukee
- Breast Cancer23 studies
- Cancer (all types)22 studies
- Non-Small Cell Lung Cancer22 studies
- Multiple Myeloma21 studies
- Lung Cancer21 studies
- Prostate Cancer20 studies
- Follicular Lymphoma19 studies
- Non-Hodgkin Lymphoma18 studies
- Pancreatic Cancer18 studies
- Acute Myeloid Leukemia17 studies
- Ovarian Cancer17 studies
- Diffuse Large B-Cell Lymphoma16 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.